The com­pany offers a mix­ture of SaaS and AIaaS, a soft­ware solu­tion that greatly sim­pli­fies the cre­ation, test­ing and imple­men­ta­tion of AI sys­tems and can be inte­grated into all devel­oped mod­els and inter­nal systems.
This soft­ware solu­tion also enables peo­ple with no knowl­edge of soft­ware devel­op­ment to cre­ate AI systems. 

The com­pany has devel­oped a com­mu­ni­ca­tion and mon­i­tor­ing sys­tem that pro­vides real-time feed­back to indi­vid­ual play­ers, groups of play­ers or the entire team dur­ing training.
This makes train­ing more effec­tive and sig­nif­i­cantly reduces inter­rup­tions to training. 

The com­pany has devel­oped soft­ware for influ­encer mar­ket­ing in SMEs that enables com­pa­nies to set up a fully in-house influ­encer mar­ket­ing process.
The soft­ware maps the entire mar­ket­ing process for han­dling influ­encer marketing. 

The com­pany spe­cial­izes in inno­va­tions for smart cities and urban mobil­ity, in par­tic­u­lar the sus­tain­able imple­men­ta­tion of safe and attrac­tive cycling infrastructure.
The data gen­er­ated by a pri­vacy-com­pli­ant safety cam­era is ana­lyzed using an urban data plat­form for cities and imple­mented in infra­struc­ture planning. 

The com­pany devel­ops and mar­kets human, life­like, minia­tur­ized organ mod­els from human cells that pre­cisely repro­duce their biol­ogy and function.
This rev­o­lu­tion­izes the devel­op­ment of new active sub­stances by increas­ing the trans­fer­abil­ity of data from drug test­ing to humans. 

The com­pany has devel­oped an IT secu­rity solu­tion for SMEs that ensures secure IT oper­a­tions with easy-to-under­stand analy­ses and spe­cific rec­om­men­da­tions for action.
This solu­tion pro­vides SMEs with con­tin­u­ous holis­tic secu­rity analy­ses and auto­mated solu­tions against cyberattacks. 

The com­pany spe­cial­izes in the pro­duc­tion of smart preser­va­tion and pack­ag­ing solu­tions that offer cor­ro­sion pro­tec­tion even under extreme conditions.
It also devel­ops and dis­trib­utes antivi­ral and antibac­te­r­ial materials. 

The com­pany has devel­oped a process with which ther­mo­plas­tics can be processed into pow­ders for addi­tive manufacturing.
The result­ing wider vari­ety of mate­ri­als and high level of effi­ciency ensure a much wider range of appli­ca­tions for 3D print­ing, includ­ing mass production. 

The com­pany solves the con­sid­er­able envi­ron­men­tal impact of fish­ing and fish farm­ing with Aqua­cul­ture 2.0 — a new dig­i­tal­ized and sus­tain­abil­ity-ori­ented recir­cu­la­tion technology.
It is used to breed fish that is exem­plary in terms of both eco­nomic and eco­log­i­cal standards. 

The com­pany offers a new type of process tech­nol­ogy for semi­con­duc­tor production.
This tech­nol­ogy opti­mizes the dop­ing of wafers for power semi­con­duc­tors and reduces pro­duc­tion costs by up to 50%. 

The com­pany offers a dig­i­tal ther­apy plat­form for men­tal health­care that inte­grates the entire treat­ment chain.
It is also set­ting up its own ther­apy cen­ters to achieve the best pos­si­ble and sus­tain­able ther­apy results for peo­ple with men­tal illnesses. 

The com­pany devel­ops and mar­kets highly reli­able mol­e­c­u­lar bio­log­i­cal tests for early detec­tion, ther­apy deci­sions and fol­low-up care in can­cer diagnostics.

The com­pany oper­ates a dig­i­tal, inde­pen­dent mar­ket­place for freight for­ward­ing trans­ports, where com­pa­nies can com­pare the prices of over 500 freight for­warders and book directly.
In addi­tion, the com­pany offers SaaS solu­tions for freight for­warders to sim­plify dig­i­tal­iza­tion, save costs and win customers. 

The com­pany devel­ops and sells poly­mer addi­tives for plastics.
These give plas­tic prod­ucts opti­mized or even new prop­er­ties, broad­en­ing the range of appli­ca­tions and improv­ing per­for­mance while reduc­ing energy and mate­r­ial con­sump­tion in plas­tics processing. 

The com­pany devel­ops and dis­trib­utes inno­v­a­tive dig­i­tal microscopy solu­tions for the dig­i­ti­za­tion of pathol­ogy, sup­port­ing med­ical pro­fes­sion­als in rapid micro­scopic assessments.
The micro­scopes are used dur­ing intra­op­er­a­tive con­sul­ta­tions for can­cer oper­a­tions and allow pathol­o­gists to check in sec­onds whether the tis­sue sur­gi­cally removed dur­ing the oper­a­tion is tumor-free at its edges. 

The com­pany acts as a “full-ser­vice provider” for the imple­men­ta­tion of med­ical care pro­grams to pre­vent strokes.
A screen­ing app is used to iden­tify and doc­u­ment the main cause of a stroke with ECG-com­pa­ra­ble accuracy. 

With its multi-dimen­sional index tech­nol­ogy, the com­pany enables the analy­sis of large vol­umes of struc­tured and unstruc­tured data.
The soft­ware prod­ucts can be eas­ily cus­tomized or inte­grated into ML/AI applications. 

The com­pany offers quan­tum-based encryp­tion tech­nolo­gies that are suit­able for both fiber net­works and QKD satel­lite networks.
In addi­tion to QKD tech­nol­ogy, the com­pany will develop com­po­nents and sys­tems for quan­tum com­put­ers and bio­med­ical imag­ing systems. 

As a sup­plier to med­ical device man­u­fac­tur­ers, the B2B com­pany devel­ops algo­rithms for cuff-based and cuf­f­less car­dio­vas­cu­lar diagnostics.
The focus is on blood pres­sure mea­sure­ment and pulse wave analy­sis, which can be used to pre­dict the devel­op­ment of arte­r­ial dis­eases and high blood pressure. 

The tech­nol­ogy com­pany offers hard­ware-based high-speed laser focus­ing, which increases the sus­tain­abil­ity of laser pro­duc­tion and laser com­mu­ni­ca­tion and thus sig­nif­i­cantly accel­er­ates laser mate­r­ial processing.

s com­pany offers switch­able pri­vacy prod­ucts using a com­bi­na­tion of hard­ware and soft­ware that can be used for mobile devices such as lap­tops, tablets and smart­phones in pub­lic spaces as well as in cars.

The com­pany is devel­op­ing a uni­ver­sal plat­form tech­nol­ogy based on func­tion­al­ized nanopar­ti­cles that can be used to trans­port active ingre­di­ents and other car­goes in the body to spe­cific cells and tissues.

The highly spe­cial­ized AI soft­ware com­pany devel­ops and dis­trib­utes safe machine learn­ing algo­rithms for the semi-autonomous and fully autonomous mobil­ity of drones, heli­copters, air cabs and vehicles.
This is made pos­si­ble by the unique fusion of var­i­ous sen­sor tech­nolo­gies with advanced AI algo­rithms and a suit­able, secure sys­tem architecture. 

The com­pany devel­ops robots that use sen­sors to con­tact­lessly detect patients and eval­u­ate their move­ments and, in future, vital data.
This sup­ports the mobi­liza­tion of patients.
In future, ther­a­peu­tic and med­ical assess­ments will also be car­ried out using robots. 

The company’s aim is to close the gap in pay­ment meth­ods for travel bookings.
The solu­tion will enable credit-financed travel book­ings at the point of sale as well as online in the future. 

The com­pany has devel­oped a soft­ware plat­form that enables the dig­i­tal imple­men­ta­tion of clin­i­cally proven therapies.
The plat­form helps with the imple­men­ta­tion of the ther­apy, links the increas­ingly dig­i­tally recorded patient obser­va­tion data with doc­tors and enables direct com­mu­ni­ca­tion with the attend­ing physician.